Email this article EFFECT OF METFORMIN AND PYOGLITAZON ON THE RISK FACTORS OF CARDIOVASCULAR PATHOLOGY DIAGNOSED DURING SCREENING OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
- Authors: Misnikova I.V.1, Dreval A.V.1, Lakeeva T.S.1
-
Affiliations:
- M.F. Vladimirsky Moscow Regional Clinical and Research Institute (MONIKI)
- Issue: No 29 (2013)
- Pages: 23-28
- Section: MODERN INVASIVE AND NON-INVASIVE DIAGNOSTIC TECHNOLOGIES AND THERAPEUTIC METHODS IN MEDICINE
- URL: https://almclinmed.ru/jour/article/view/26
- DOI: https://doi.org/10.18786/2072-0505-2013-29-23-28
- ID: 26
Cite item
Full Text
Abstract
Under assessment there was metformin and pyoglitazon effect on the risk factors of cardiovascular disease. During treatment of patients with screening-diagnosed type 2 diabetes mellitus, the following changes were noted: decreasing the levels of glycated hemoglobin, Willebrand factor and C-reactive protein, and increasing the level of HDL cholesterol. It was shown that 6-month-long therapy with metformin and pyoglItazon allowed significant improving glycemia control and influencing markers of cardiovascular risk in these patients.
About the authors
I. V. Misnikova
M.F. Vladimirsky Moscow Regional Clinical and Research Institute (MONIKI)
Author for correspondence.
Email: fake@neicon.ru
Russian Federation
A. V. Dreval
M.F. Vladimirsky Moscow Regional Clinical and Research Institute (MONIKI)
Email: fake@neicon.ru
Russian Federation
T. S. Lakeeva
M.F. Vladimirsky Moscow Regional Clinical and Research Institute (MONIKI)
Email: fake@neicon.ru
Russian Federation
References
- Древаль А.В., Мисникова И.В., Барсуков И.А. Лечение ранних нарушений углеводного обмена // Леч. врач. 2008. №10. С.36-39.
- Мисникова И.В., Древаль А.В., Ковалева Ю.А. Риски общей и сердечно-сосудистой смертности, а также инфаркта миокарда и острого нарушения мозгового кровообращения у больных сахарным диабетом 2 типа в зависимости от вида стартовой сахароснижающей терапии // Сахарный диабет. 2009. №4. С.72-76.
- Мкртумян А.М., Аметов А.С., Суркова Е.В. и др. Алгоритмы специализированной медицинской помощи больным сахарным диабетом / под ред. И.И. Дедова, М.В. Шестаковой // Cахарный диабет. 2011. №3. Приложение.
- DECODE Study Group, the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria // Arch. Intern. Med. 2001. V.161. P.397-405.
- Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Geneva: WHO, 1999. 46 p.
- Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study // Lancet. 2009. V.374. P.1677-1686.
- Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin // N. Engl. J. Med. 2002. V.346. P.393-403.
- Gore O., McGuire D. The 10-year post-trial follow-up of the United Kingdom Prospective Diabetes Study (UKPDS): cardiovascular observations in context // Diab. Vasc. Dis. Res. 2009. V.6. P.53.
- International Diabetes Federation. Global Guideline for Type 2 Diabetes. 2005. P.35-36.
- International Diabetes Federation. The Diabetes Atlas. 3th ed. 2006; 4th ed. 2009.
- Inzucchi S.E., Bergenstahl R.M., Buse J.B. et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach // Diabetes Care. 2012. V.35.
- Nathan D.M., Buse J.B., Davidson M.B. et al. Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy // Diabetes Care. 2009. V.31. P.1-11.
- Qiao Q., Lindstrom J., Valle T. et al. Progression to clinically diagnosed and treated diabetes from impaired glucose tolerance and impaired fasting glycemia // Diabet Med. 2003. V.20. P.1027-1033.
- Selvin E., Steffes M.W., Zhu H. et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults // N. Engl. J. Med. 2010. V.362, No.9. P.800-811.
- Тuomilehto J., Lindstrom J., Eriksson J. et al. Prevention on type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance // N. Engl. J. Med. 2001. V.344. P.1343-1350.
Supplementary files
